7WS-29585-23909 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-05-18
Dose 1 — Pfizer-BioNTech
2021-06-08
Dose 2 — Pfizer-BioNTech
2021-07-10
Registered in v-safe
2021-07-10
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-07-13
Health check-in — day 35, dose 2
Feeling: Fair

Adult check-in
2021-07-20
Health check-in — day 42, dose 2
Feeling: Fair

Adult check-in
2021-09-09
Health check-in — 3 months, dose 2
Feeling: Fair

Adult check-in
2021-12-10
Dose 3 — Pfizer-BioNTech
2021-12-12
Health check-in — 6 months, dose 2
Feeling: Fair

Adult check-in
2021-12-12
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-12-13
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · None

Adult check-in
2021-12-16
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-12-18
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-12-24
Health check-in — day 14, dose 3
Feeling: Fair

Adult check-in
2022-01-01
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2022-01-16
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-03-11
Survey response — 3 months, dose 3
MedDRA: Cough, Fatigue, Headache, Oropharyngeal pain, Pain, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: headache, fever, fatigue, body aches, dry cough, sore throat

MedDRA releases: 2024-11 · check-in free text available
2022-03-11
Report sent to call center — 3 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2022-03-15
Call 1 — Left Voicemail
2022-06-11
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-12-12
Survey response — 12 months, dose 3
MedDRA: Cough, Unevaluable event — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

Free text: Symptoms: coughing · Healthcare visit (other): none

MedDRA releases: 2024-11 · check-in free text available
2022-12-12
Report sent to call center — 12 months, dose 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2022-12-13
Call 2 — Left Voicemail
2022-12-13
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-05-18	Pfizer-BioNTech	No
2	2021-06-08	Pfizer-BioNTech	No
3	2021-12-10	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-03-11	Unsuccessful
2022-12-12	Unsuccessful

Free text

Release 11 — 3 months, dose 3

2022-03-11

Symptoms: headache, fever, fatigue, body aches, dry cough, sore throat

Release 12 — 12 months, dose 3

2022-12-12

Symptoms: coughing

Healthcare visit (other): none

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Unevaluable event	·	·	✓
SD	Cough	·	·	✓
SD	Fatigue	·	·	✓
SD	Headache	·	·	✓
SD	Oropharyngeal pain	·	·	✓
SD	Pain	·	·	✓
SD	Pyrexia	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release